Literature DB >> 9058866

Dual chamber pacing in hypertrophic obstructive cardiomyopathy: beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling.

X Jeanrenaud1, J Schläpfer, M Fromer, N Aebischer, L Kappenberger.   

Abstract

Clinical improvement with dual chamber pacing has largely been reported in patients suffering from hypertrophic obstructive cardiomyopathy and mainly attributed to the reduction of the subaortic pressure gradient. To be effective, pacing must induce a permanent and complete capture of the LV. In two patients of our collective, symptoms (angina and dyspnea NYHA Class III and/or syncopes) persisted or relapsed despite pacing. This was related to the inability to obtain full LV capture due to a too-short native PR interval. RF ablation of the AV junction was therefore performed in both patients, resulting in permanent AV block in one and prolonged PR interval up 310 ms in the second. Pacing was thereafter associated with an immediate and significant clinical improvement related to permanent LV capture, whatever the patient's activity. After RF ablation, the AV delay was set up to induce the best LV filling, as assessed by Doppler analysis of mitral flow. Our observations suggest that RF ablation or modification of the AV junction can be a successful procedure in some patients with residual or recurrent symptoms, when the latter result from a loss of capture or from the inability to program an AV delay that does not compromise the active component to LV filling. Doppler echocardiography is a simple and effective mean to assess the hemodynamic effect of AV interval modulation in this setting.

Entities:  

Mesh:

Year:  1997        PMID: 9058866     DOI: 10.1111/j.1540-8159.1997.tb06173.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

Review 1.  Dual-chamber pacing in hypertrophic cardiomyopathy.

Authors:  D M Gilligan
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

2.  Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients.

Authors:  Antonio Berruezo; Markus Linhart; Angelo Auricchio; José Luis Zamorano; Pilar Santamaria; Roger Borràs; Felip Burgos; Josep Brugada
Journal:  J Interv Card Electrophysiol       Date:  2018-02-03       Impact factor: 1.900

3.  Current management of hypertrophic cardiomyopathy.

Authors:  Caroline J Coats; Perry M Elliott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-12

4.  Biventricular / left ventricular pacing in hypertrophic obstructive cardiomyopathy: an overview.

Authors:  Radu Vatasescu; Reinder Evertz; Lluis Mont; Marta Sitges; Josep Brugada; Antonio Berruezo
Journal:  Indian Pacing Electrophysiol J       Date:  2012-05-20

Review 5.  Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy.

Authors:  José Maria Tolosana; Emilce Trucco
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

6.  Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials.

Authors:  Ahran D Arnold; James P Howard; Kayla Chiew; William J Kerrigan; Felicity de Vere; Hannah T Johns; Leonid Churlilov; Yousif Ahmad; Daniel Keene; Matthew J Shun-Shin; Graham D Cole; Prapa Kanagaratnam; S M Afzal Sohaib; Amanda Varnava; Darrel P Francis; Zachary I Whinnett
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.